Therapeutic area intelligence for Endometriosis with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 3
Catalysts: 0
Companies: 0

Companies

No related entities indexed yet.

Assets

NINDS →

Recent signals(3)

ClinicalJune 25, 2026

Study on Pelvic Pain in Women with Endometriosis to Explore Treatment Approaches

A study sponsored by NINDS is investigating pelvic pain in women with endometriosis, focusing on hormonal and genetic factors.

ClinicalJune 25, 2026

UK-wide ENDO1000 Study Aims to Advance Endometriosis Diagnosis and Treatment

The ENDO1000 study will collect extensive longitudinal data from 3000 individuals with endometriosis to improve diagnosis and treatment.

Clinical

June 22, 2026

Study on ICG for Enhanced Visualization of Ureters in Deep Infiltrating Endometriosis

A clinical trial is investigating the use of ICG for improved visualization of ureters during laparoscopic surgery in patients with deep infiltrating endometriosis.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

No related entities indexed yet.

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.